Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kluft

Showing results (131-140 of 230) with videos related to

Pageof 23
Sort By:
Thrombosis and Haemostasis|March 1, 1995
Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent wayB C Hennis, D I Boomsma, K Fijnvandraat, et al.
Diabetes Care|August 1, 1992
Fibrinolytic system during long-distance running in IDDM patients and in healthy subjectsB J van Loon, L P Heere, C Kluft, et al.
Thrombosis and Haemostasis|January 23, 1991
Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasmaG Dooijewaard, A de Boer, P N Turion, et al.
Thrombosis and Haemostasis|November 3, 1998
Genetic modulation of coagulation factor VII plasma levels: contribution of different polymorphisms and gender-related effectsA Di Castelnuovo, A D'Orazio, C Amore, et al.
The American Journal of Cardiology|November 15, 1991
Effect of propranolol (long-acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1F Andreotti, C Kluft, G J Davies, et al.
Journal of the American College of Cardiology|May 1, 1990
Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasminF W Leebeek, C Kluft, E A Knot, et al.
Human Genetics|February 1, 1986
Assignment of the human tissue-type plasminogen activator gene (PLAT) to chromosome 8J H Verheijen, R Visse, J T Wijnen, et al.
Arzneimittel-Forschung|March 1, 1988
Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteersE Seifried, P Tanswell, D C Rijken, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The association between birth weight and plasma fibrinogen is abolished after the elimination of genetic influencesR G Ijzerman, C D A Stehouwer, E J de Geus, et al.
The Journal of Infectious Diseases|February 18, 1998
CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasoneJ Visser, B Blauw, B Hinloopen, et al.
Pageof 23

Showing results (131-140 of 230) with videos related to

Sort By:
Pageof 23
Thrombosis and Haemostasis|March 1, 1995
Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent wayB C Hennis, D I Boomsma, K Fijnvandraat, et al.
Diabetes Care|August 1, 1992
Fibrinolytic system during long-distance running in IDDM patients and in healthy subjectsB J van Loon, L P Heere, C Kluft, et al.
Thrombosis and Haemostasis|January 23, 1991
Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasmaG Dooijewaard, A de Boer, P N Turion, et al.
Thrombosis and Haemostasis|November 3, 1998
Genetic modulation of coagulation factor VII plasma levels: contribution of different polymorphisms and gender-related effectsA Di Castelnuovo, A D'Orazio, C Amore, et al.
The American Journal of Cardiology|November 15, 1991
Effect of propranolol (long-acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1F Andreotti, C Kluft, G J Davies, et al.
Journal of the American College of Cardiology|May 1, 1990
Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasminF W Leebeek, C Kluft, E A Knot, et al.
Human Genetics|February 1, 1986
Assignment of the human tissue-type plasminogen activator gene (PLAT) to chromosome 8J H Verheijen, R Visse, J T Wijnen, et al.
Arzneimittel-Forschung|March 1, 1988
Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteersE Seifried, P Tanswell, D C Rijken, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The association between birth weight and plasma fibrinogen is abolished after the elimination of genetic influencesR G Ijzerman, C D A Stehouwer, E J de Geus, et al.
The Journal of Infectious Diseases|February 18, 1998
CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasoneJ Visser, B Blauw, B Hinloopen, et al.
Pageof 23